To qualify for Semaglutide GLP-1, patients generally need to meet specific criteria related to their health and weight status
Body weight in the semaglutide group decreased by an estimated 6.8 kg more than placebo, confirming the expected weight loss effect, but the bone changes occurred in parallel rather than being fully explained by mechanical unloading from weight loss alone
People who want in-person visits and hands-on support
Based on Phase 2 clinical trial data (Jastreboff et al., NEJM , 2023), retatrutide is administered using a gradual dose escalation schedule
Use in conjunction with any sensible diet and exercise program
If you want to explore your eligibility for GLP-1 or GIP/GLP-1 treatments today, Heally can connect you to a licensed provider who helps assess your situation and determine whether one of the approved drugs might be right for you